Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SalbuEase: Nebulized Salbutamol for Acute Renal Colic
NCT06276231Not yet recruiting
- Sponsor
- Oman Medical Specialty Board
- Start
- Jul 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in Renal colic comparing Salbutamol + Diclofenac with Placebo + Diclofenac (2 arms). Primary endpoint: Pain reduction at 60 minutes. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
Renal colic
Beyond the preview
Go deeper on NCT06276231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06276231.